These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25842218)

  • 21. Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.
    Bragazzi NL; Orsi A; Ansaldi F; Gasparini R; Icardi G
    Hum Vaccin Immunother; 2016 Oct; 12(10):2616-2627. PubMed ID: 27246556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
    Foy JE; Hendriksz T; Malouf P; Tobin A
    J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New emerging technologies and the intradermal route: the novel way to immunize against influenza.
    Falsey AR
    Vaccine; 2010 Sep; 28 Suppl 4():D24-32. PubMed ID: 20713257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents.
    Marshall S; Fleming A; Moore AC; Sahm LJ
    Vaccine; 2017 Sep; 35(37):4896-4904. PubMed ID: 28780122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes and perceptions among the pediatric health care providers toward influenza vaccination in Qatar: A cross-sectional study.
    Alhammadi A; Khalifa M; Abdulrahman H; Almuslemani E; Alhothi A; Janahi M
    Vaccine; 2015 Jul; 33(32):3821-8. PubMed ID: 26144904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.
    Kharbanda EO; Vazquez-Benitez G; Shi WX; Lipkind H; Naleway A; Molitor B; Kuckler L; Olsen A; Nordin JD
    Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S47-51. PubMed ID: 22920059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microneedle and mucosal delivery of influenza vaccines.
    Kang SM; Song JM; Kim YC
    Expert Rev Vaccines; 2012 May; 11(5):547-60. PubMed ID: 22697052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The time has come to change the influenza vaccination strategy].
    Kiro A; Mor Z
    Harefuah; 2008 Dec; 147(12):993-4, 1028. PubMed ID: 19260598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reactogenicity and immunogenicity of intradermal flu vaccine among the medical students of the University of Rome Tor Vergata].
    Morciano L; Zaratti L; Carlino C; Visconti G; Magrini A; Franco E
    Ig Sanita Pubbl; 2012; 68(5):749-58. PubMed ID: 23223323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of influenza vaccines in pregnant women.
    Munoz FM
    Am J Obstet Gynecol; 2012 Sep; 207(3 Suppl):S33-7. PubMed ID: 22920057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges and opportunities in the Israeli 2009 pandemic influenza vaccination program.
    Levine H; Balicer RD; Laor D; Grotto I
    Hum Vaccin; 2011 Oct; 7(10):1077-82. PubMed ID: 21941096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
    Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.
    Lu PJ; Santibanez TA; Williams WW; Zhang J; Ding H; Bryan L; O'Halloran A; Greby SM; Bridges CB; Graitcer SB; Kennedy ED; Lindley MC; Ahluwalia IB; LaVail K; Pabst LJ; Harris L; Vogt T; Town M; Singleton JA;
    MMWR Surveill Summ; 2013 Oct; 62(4):1-28. PubMed ID: 24157710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.
    Pearton M; Pirri D; Kang SM; Compans RW; Birchall JC
    Adv Healthc Mater; 2013 Oct; 2(10):1401-10. PubMed ID: 23564440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seasonal and pandemic influenza vaccine: recommendations to families of at-risk children during the 2009-10 season.
    Romano M; Pandolfi E; Marino MG; Gesualdo F; Rizzo C; Carloni E; Macchiaiolo M; Tozzi AE
    Eur J Public Health; 2012 Dec; 22(6):821-4. PubMed ID: 22315460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study.
    Durando P; Alicino C; Alberti M; Sticchi L; Turello V; Marensi L; Caiazzo AL; Panico MG; Giugliano F; Parlato A; Peluso F; Sgricia S; Icardi G;
    Adv Ther; 2012 Apr; 29(4):312-26. PubMed ID: 22529024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.